Dhruv Agrawal

Dhruv Agrawal

Active Director Director DIN 07843595
DIN 07843595 First appointment Jul 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Dhruv Agrawal

Data last updated:

Dhruv Agrawal is a Director at Aether Biomedical Private Limited (since 2017). The company operates in Healthcare.

DIN 07843595
Primary Designation Director
Industry Healthcare
First Appointment 18 Jul 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aether Biomedical Private Limited U33309DL2017PTC320799
Director18 Jul 20172017Active

Board colleagues of Dhruv Agrawal

NameDINCompanyDesignation
Faith Jiwakhan07843502Aether Biomedical Private LimitedDirector
Nisha07843404Aether Biomedical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aether Biomedical Private Limited
Premium access

Shareholding and investment profile for Dhruv Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhruv Agrawal

Dhruv Agrawal currently holds 1 directorship: Aether Biomedical Private Limited (Director, since 18 Jul 2017).

Dhruv Agrawal was first appointed on 18 Jul 2017 as Director at Aether Biomedical Private Limited.

The current boards of Dhruv Agrawal's companies include Faith Jiwakhan (Aether Biomedical Private Limited), Nisha (Aether Biomedical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available